Ad hoc announcement: Change in the Supervisory Board

Frankfurt, 14 April 2005 - As a consequence of the published changes in the interests held by the private shareholders of the foundation members, the Supervisory Board Members who have accompanied the company since the foundation of MediClin, have resigned from their offices after the end of this year’s general annual meeting on May 25, 2005. This relates to the Supervisory Board seats of Prof. Dr. Gerhard Schmidt (Supervisory Board Chairman), Prof. Dr. Peter Reichling and Mr. Bernd Schirmer. A successor regulation concerning the Supervisory Board seat of a shareholder of the insurance companies is upcoming. Here Mr. Frank-Rainer Vaessen (Ergo Group) will resign from office as of 25 May 2005.

The Supervisory Board will propose to the general annual meeting in the agenda for this meeting its notification of new members.

WKN: 659510; ISIN: DE0006595101
Listed: official market in Frankfurt (Prime Standard); off-board trading at Berlin-Bremen, Düsseldorf, Hamburg and Stuttgar